• 270articles · 30d
  • 9+ hour agolatest article
  • Aug 18, 2026earliest in window
  • 99%with images
  • 248avg words
articles per day
Categories
  • Economy, Business & Finance 228
  • Finance & Business 167
  • News 115
  • Business & Industrial 78
  • Industrial 25
  • Science & Technology 21
  • Health & Wellness 20
  • Medical 18

Please confirm you are human

This browser or connection looks automated. Press and continuously hold the control for 3 seconds to enable Google-hosted web results and, when separately allowed, AI-assisted answers.

A successful check enables 100 search requests. Interactive access does not authorize scraping, systematic collection, or reuse of search output.

Hold with a pointer, or hold Space or Enter.

News

Via Ritzau
via.ritzau.dk > pressemeddelelse > 15/14/8828 > onward-medical-nv

ONWARD Medical NV | Globenewswire

5+ day, 6+ hour ago   (552+ words) ONWARD Medical Reports First Half 2026 Results with Strong Product Revenue Growth and Continued Progress across ARC Therapy Pipeline THIS PRESS RELEASE CONTAINS INSIDE INFORMATION WITHIN THE MEANING OF ARTICLE 7(1) OF THE EUROPEAN MARKET ABUSE REGULATION (596/2014) EINDHOVEN, the Netherlands, Sept. 09, 2026 (GLOBE…...

Via Ritzau
via.ritzau.dk > pressemeddelelse > 15/14/6300 > greywolf-therapeutics

Greywolf Therapeutics | Globenewswire

6+ day, 5+ hour ago   (417+ words) Greywolf Therapeutics doses first participants with axSpA in novel ERAP1 inhibitor trial OXFORD, United Kingdom, Sept. 08, 2026 (GLOBE NEWSWIRE) -- Greywolf Therapeutics, the clinical-stage biotech company advancing novel antigen modulation treatments for cancer and autoimmune diseases, today reports significant progress in their Phase…...

via.ritzau.dk
via.ritzau.dk > pressemeddelelse > 15/14/4830 > novo-nordisk-as

Novo Nordisk A/S | Globenewswire

1+ week, 1+ hour ago   (184+ words) The overall safety and tolerability of semaglutide observed in STEP Young were consistent with previous Novo Nordisk paediatric and adult trials with semaglutide and liraglutide, and no new safety concerns were identified. Furthermore, no safety concerns were identified for growth…...

Via Ritzau
via.ritzau.dk > pressemeddelelse > 15/13/0579 > lipotype-gmbh

Lipotype GmbH | Globenewswire

1+ week, 5+ day ago   (237+ words) Research Team Wins Heinz Maurer Award for Linking Bacterium to Eczema Barrier Failure The team combined lipidomics, profiling the fatty molecules forming the skin's outermost layer, with microbiome profiling, identifying bacterial communities on the skin's surface. Both were performed on…...

Via Ritzau
via.ritzau.dk > pressemeddelelse > 15/12/9043 > medicel-ag

Medicel AG | Globenewswire

1+ week, 6+ day ago   (436+ words) Medicel AG expands its SOFT TIP I/A portfolio with the launch of BICEL™ SOFT TIP I/A terralution™ – bimanual sustainable I/A (irrigation / aspiration) for gentle tissue interaction – at the ESCRS Congress 2026 in London. ALTENRHEIN, Switzerland, Sept. 01, 2026 (GLOBE NEWSWIRE)…...

Via Ritzau
via.ritzau.dk > pressemeddelelse > 15/12/6098 > beone-medicines-announces-new-phase-3-survival-data-reinforcing-benefit-of-ziihera-containing-regimens-in-first-line-her2-gastroesophageal-cancer

BeOne Medicines Announces New Phase 3 Survival Data Reinforcing Benefit of ZIIHERA-Containing Regimens in First-Line HER2+ Gastroesophageal Cancer | Business Wire

2+ week, 1+ hour ago   (197+ words) 31.8.2026 12:00:00 CEST | Business Wire | Press release Findings provide further evidence of overall survival benefit of TEVIMBRA plus ZIIHERA and chemotherapy regimen in HER2+ GEAZIIHERA plus chemotherapy demonstrated statistically significant overall survival benefit at second interim analysis of HERIZON-GEA-01 trial Mark Lanasa, M.D., Ph....

Google News
via.ritzau.dk > pressemeddelelse > 15/11/1406 > lakefront-biotherapeutics

Lakefront Biotherapeutics | Globenewswire

2+ week, 6+ day ago   (89+ words) U.S. FDA Grants Orphan Drug Designation to Gamgertamig for the Treatment of Pemphigus Gamgertamig is being developed by Lakefront in collaboration with Gilead Sciences. Ongoing clinical trials in autoimmune diseases are actively enrolling, and expansion of the clinical trials program is…...

Via Ritzau
via.ritzau.dk > pressemeddelelse > 15/10/9556 > american-case-management-association

American Case Management Association | Globenewswire

3+ week, 2+ hour ago   (306+ words) LONDON, UK, Aug. 24, 2026 (GLOBE NEWSWIRE) -- Healthcare professionals from across the United Kingdom and around the world will have the opportunity to earn recognised Continuing Professional Development (CPD) credit while exploring the future of integrated healthcare at the inaugural International Case…...